Funding

Capital tied to evidence and the next proof point.

Anthovian is pursuing non-dilutive grants and seed investment to advance research, prototype development, partner readiness and responsible pilot design.

Funding approachNo public target amount.

Anthovian is opening conversations without publishing an amount, valuation or investment terms on this website.

01Non-dilutive

Grants

Digital-health, public-impact, research and innovation grants can support evidence generation, governance and prototype work.

Discuss a grant
02Early stage

Seed investment

Anthovian welcomes digital-health, impact, venture and strategic healthcare investors aligned with a responsible Thailand-first pathway.

Discuss investment

Use of funding

Fund the pipeline, not a premature scale story.

01

Product & prototype

Translate the validated journey into a usable, testable product experience.

02

Partner integration

Prepare clinic and pharmacy workflows for a narrowly defined pilot.

03

Safety & governance

Advance privacy, security, professional responsibility and operating controls.

04

Research & validation

Analyse survey evidence and test assumptions with target participants.

05

Pilot readiness

Build the processes, partner materials and measurement plan needed for responsible testing.

Milestones

What the next funding should make possible.

  1. Publish reviewed research findings
  2. Complete an interactive prototype
  3. Define a partner-ready pilot
  4. Document governance and compliance requirements
  5. Establish measurable pilot success criteria
Anthovian

Investor overview

Download the Anthovian investor deck.

A concise overview of the problem, Thailand evidence, platform journey, pipeline, governance and founder story.

Download deck

Discuss funding

anthovian.funding@outlook.com

Start a conversationThis material is informational and is not a public securities offer.